Fortitude Family Office’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.04K Hold
8
– – ﹤0.01% 1681
2026
Q2
$3.73K Buy
8
+4
+100% +$1.68K ﹤0.01% 1213
2026
Q1
$1.51K Sell
4
-19
-83% -$8.14K ﹤0.01% 1378
2025
Q4
$9.84K Buy
23
+21
+1,050% +$9.14K ﹤0.01% 586
2025
Q3
$895 Sell
2
-4
-67% -$1.81K ﹤0.01% 1591
2025
Q2
$2.92K Buy
6
+3
+100% +$1.71K ﹤0.01% 1021
2025
Q1
$1.85K Sell
3
-4
-57% -$2.27K ﹤0.01% 933
2024
Q4
$3.71K Hold
7
– – ﹤0.01% 914
2024
Q3
$4.21K Buy
+7
New +$3.97K ﹤0.01% 835

Other funds holding CHE

Fortitude Family Office's CHE Position: Q3 2026 in Review

Fortitude Family Office held its Chemed (CHE) position steady in Q3 2026 at 8 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Fortitude Family Office first reported a position in CHE in Q3 2024 and has held it in 9 quarters since. The position peaked at $9.84K in Q4 2025. 42 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Fortitude Family Office held 8 shares of Chemed worth $4.04K as of Q3 2026.
  • Fortitude Family Office left its Chemed share count unchanged in Q3 2026.
  • Chemed made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1681 holding.
  • Fortitude Family Office first reported a position in Chemed in Q3 2024 and has held it in 9 quarters since.
  • Fortitude Family Office's Chemed position peaked at $9.84K in Q4 2025.
  • 42 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.